Shire, the maker of Vyvanse and Adderall – is potentially a target for acquisition by larger multinational pharmaceutical companies. What will this mean to the market of ADHD medications? That’s unclear.
If you read to halfway down this article – you will learn that Shire is trying to switch everyone from Adderall XR to Vyvanse, because Adderall is losing its patent very soon.
It is a very strategic process…